CDC advisers vote to overturn decades-long policy on hepatitis B vaccine for infants

Pien Huang

December 05, 2025 / 8:20 am

In a historic vote, the Centers for Disease Control and Prevention's vaccine advisers recommended narrowing the agency's hepatitis B immunization guidance for newborns.

The result, if approved by the CDC's acting director, will be a rollback of a universal recommendation to start hepatitis B immunization at birth, a standard practice in the U.S. for more than 30 years that has been credited with dramatically lowering liver diseases caused by the virus.

The Advisory Committee on Immunization Practices, or ACIP, voted 8-3 to recommend hepatitis B at birth only for infants born to women who test positive for the virus that attacks the liver. Women whose hepatitis

See Full Page